# Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer

> **NCT06235853** · — · COMPLETED · sponsor: **Wroclaw Medical University** · enrollment: 240 (actual)

## Conditions studied

- Non-muscle Invasive Bladder Cancer
- Cystoscopy
- Recurrence
- Progression
- Bladder Cancer
- Biomarkers

## Interventions

- **DIAGNOSTIC_TEST:** Blood serum: sUPAR, PAI-1, IL-8.
- **DIAGNOSTIC_TEST:** Urine: IL-8, APOE, VEGF.

## Key facts

- **NCT ID:** NCT06235853
- **Lead sponsor:** Wroclaw Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-04-30
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06235853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06235853, "Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06235853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*